During the past decade, Eduardo Tibiriçá conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eduardo Tibiriçá" are "Arterial Hypertension" (1 trials), "Endothelial Dysfunction" (1 trials), "Endothelial Function" (1 trials), "Laparoscopic Surgery" (1 trials) and "Microvascular Rarefaction" (1 trials). Many other conditions were trialed in "Eduardo Tibiriçá" in a lesser frequency.

Most popular intervention types in "Eduardo Tibiriçá" are "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.9%sodium chloride" (1 trials), "Evaluation of systemic skin microvascular endothelial function" (1 trials), "Ingestion of mineral water" (1 trials), "Ingestion of the energy drink (Red Bull®)" (1 trials) and "dexmedetomidine intravenous infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eduardo Tibiriçá" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Eduardo Tibiriçá". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Eduardo Tibiriçá, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eduardo Tibiriçá, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".